Liraglutide, a Once-Daily Human GLP-1 Analog, Reduces Systolic Blood Pressure with Minimal Impact from Weight Loss in Subjects with Type 2 Diabetes.

被引：0
|
作者：
Henry, R. R. [1 ]
Fonseca, V. [2 ]
Tabanera y Palacios, R. [3 ]
Brett, J. [4 ]
Plutzky, J. [5 ]
机构：
[1] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[2] Tulane Univ, Med Ctr, New Orleans, LA USA
[3] Novo Nordisk AS, Copenhagen, Denmark
[4] Novo Nordisk Inc, Princeton, NJ USA
[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] In subjects with type 2 diabetes, liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure with negligible impact from weight loss
    Fonseca, V. A.
    Henry, R. R.
    Tabanera y Palacios, R.
    Brett, J.
    Plutzky, J.
    DIABETOLOGIA, 2010, 53
  • [2] The once-daily human GLP-1 analog-liraglutide reduces systolic blood pressure in patients with type 2 diabetes
    Colagiuri, Steven
    Frid, Anders
    Zdravkovic, Milan
    Le-Thi, Tu Duyen
    Vaag, Allan
    DIABETES, 2008, 57 : A164 - A165
  • [3] The once-daily human GLP-1 analog liraglutide reduces body weight in subjects with type 2 diabetes, irrespective of body mass index at baseline
    Russell-Jones, David
    Shaw, Jonathan E.
    Brandle, Michael
    Matthews, David
    Frid, Anders
    Zdravkovic, Milan
    Schmitz, Ole
    DIABETES, 2008, 57 : A593 - A594
  • [4] Liraglutide, a human GLP-1 analogue, reduces systolic blood pressure in subjects with type 2 diabetes
    Colagiuri, S.
    Frid, A.
    Zdravkovic, M.
    Le-Thi, T. D.
    Vaag, A.
    Garber, A.
    Zinman, B.
    DIABETOLOGIA, 2008, 51 : S359 - S360
  • [5] Liraglutide, a once-daily human GLP-1 analog, significantly improves β-cell function in subjects with type 2 diabetes
    Matthews, David
    Marre, Michel
    Le-Thl, T. U. Duyen
    Zdravkovic, Milan
    Simo, Rafael
    DIABETES, 2008, 57 : A150 - A151
  • [6] Liraglutide, a Once-Daily Human GLP-1 Analog, Lowers Systolic Blood Pressure (SBP) Independently of Concomitant Antihypertensive Treatment
    Fonseca, Vivian
    Plutzky, Jorge
    Montanya, Eduard
    Colagiuri, Stephen
    Hansen, Charlotte
    Falahati, Ali
    Devries, J. Hans
    DIABETES, 2010, 59 : A79 - A79
  • [7] Mechanism of Protraction for Liraglutide, the Once-Daily Human GLP-1 Analog
    Knudsen, Lotte B.
    Nielsen, Per F.
    Steensgaard, Dorte B.
    Bloch, Paw
    Lau, Jesper
    Agersoe, Henrik
    DIABETES, 2009, 58 : A532 - A532
  • [8] Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
    Astrup, A.
    Carraro, R.
    Finer, N.
    Harper, A.
    Kunesova, M.
    Lean, M. E. J.
    Niskanen, L.
    Rasmussen, M. F.
    Rissanen, A.
    Rossner, S.
    Savolainen, M. J.
    Van Gaal, L.
    INTERNATIONAL JOURNAL OF OBESITY, 2012, 36 (06) : 843 - 854
  • [9] Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
    A Astrup
    R Carraro
    N Finer
    A Harper
    M Kunesova
    M E J Lean
    L Niskanen
    M F Rasmussen
    A Rissanen
    S Rössner
    M J Savolainen
    L Van Gaal
    International Journal of Obesity, 2012, 36 : 843 - 854
  • [10] Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes
    Ryan, Gina J.
    Hardy, Yolanda
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 260 - 274
12345